Co-expression of HoxA9 and bcr-abl genes in chronic myeloid leukemia

Leukemia and Lymphoma

Volumn 51, Issue 5, 2010, Pages 892-896

  Tedeschi, Fabián A ^a   Cardozo, Maria A ^a   Valentini, Rosanna ^b   Zalazar, Fabin E ^a  

^a UNIVERSIDAD NACIONAL DEL LITORAL   (Argentina)

^b Hospital JBIturraspe Santa Fe   (Argentina)

Author keywords

Bcr abl; CML; Gene expression; HoxA9; RT PCR

Indexed keywords

ABELSON KINASE; BCR ABL PROTEIN; TRANSCRIPTION FACTOR HOXA9; TRANSCRIPTION FACTOR JUNB;

ACUTE LYMPHOCYTIC LEUKEMIA; ADULT; ARTICLE; BLAST CELL CRISIS; CANCER GROWTH; CHROMOSOME TRANSLOCATION; CHRONIC MYELOID LEUKEMIA; CLINICAL ARTICLE; FEMALE; GENE EXPRESSION; GENE REARRANGEMENT; HUMAN; MALE; PRIORITY JOURNAL; PROGNOSIS; PROTEIN EXPRESSION; PROTEIN FUNCTION; REVERSE TRANSCRIPTION POLYMERASE CHAIN REACTION; RISK FACTOR;

ADULT; FEMALE; FOLLOW-UP STUDIES; FUSION PROTEINS, BCR-ABL; GENE EXPRESSION; HOMEODOMAIN PROTEINS; HUMANS; LEUKEMIA, MYELOGENOUS, CHRONIC, BCR-ABL POSITIVE; MALE; MIDDLE AGED; PROGNOSIS; REVERSE TRANSCRIPTASE POLYMERASE CHAIN REACTION; RNA, MESSENGER;

EID: 77951770184     PISSN: 10428194     EISSN: 10292403     Source Type: Journal    
DOI: 10.3109/10428190903586326     Document Type: Article

References (26)

1. Ren R. Mechanisms of BCR-ABL in the pathogenesis of chronic myelogenous leukaemia. Nat Rev Cancer 2005;5:172-183.
2. Calabretta B, Perrotti D. The biology of CML blast crisis. Blood 2004;103:4010-4020.
3. Dorsam ST, Ferrell CM, Dorsam GP, et al. The transcriptome of the leukemogenic homeoprotein HOXA9 in human hematopoietic cells. Blood 2004;103:1676-1684.
4. Janssen JJ, Klaver SM, Waisfisz Q, et al. Identification of genes potentially involved in disease transformation of CML. Leukemia 2005;19:998-1004.
5. Lawrence J, Sauvageau G, Humphries RK, Largmana C. The role of HOX homeobox genes in normal and leukemic hematopoiesis. Stem Cells 1996;14:281-291.
6. Dash AB, Williams IR, Kutok JL, et al. A murine model of CML blast crisis induced by cooperation between BCR-ABL and NUP98-HOXA9. PNAS 2002;99:7622-7627.
7. Tedeschi FA, Zalazar FE. HOXA9 gene expression in the chronic myeloid leukemia progression. Leuk Res 2006;30:1453-1456.
8. Sokal JE, Cox EB, Baccarani M, et al. Prognostic discrimination in 'good-risk' chronic granulocytic leukemia. Blood 1984;63:789-799.
9. Hughes T, Deininger M, Hochhaus A, et al. Monitoring CML patients responding to treatment with tyrosine kinase inhibitors: review and recommendations for harmonizing current methodology for detecting BCR-ABL transcripts and kinase. Blood 2006;108:28-37.
10. Cross NCP, Melo JV, Feng L, Goldman JM. An optimized multiplex polymerase chain reaction (PCR) for detection of BCR-ABL fusion mRNAs in hematological disorders. Leukemia 1994;58:186-189.
11. Hughes TP, Morgan GJ, Martiat P, Goldman JM. Detection of residual leukemia after bone marrow transplant for chronic myeloid leukemia: role of polymerase chain reaction in predicting relapse. Blood 1991;77:874-878.
12. Quentmeier H, Dirks WG, Macleod RA, Reinhardt J, Zaborski M, Drexler HG. Expression of HOX genes in acute leukemia cell lines with and without MLL translocations. Leuk Lymphoma 2004;45:567-574.
13. Yang MY, Liu TC, Chang JG, Lin PM, Lin SF. JunB gene expression is inactivated by methylation in chronic myeloid leukemia. Blood 2003;101:3205-3211.
14. Neumaier M, Braun A, Wagener C. Fundamentals of quality assessment of molecular amplification methods in clinical diagnostics. International Federation of Clinical Chemistry Scientific Division Committee on Molecular Biology Techniques. Clin Chem 1998;4:12-26.
15. Calvo KR, Sykes DB, Pasillas M, Kamps MP. Hoxa9 immortalizes a granulocyte-macrophage colony-stimulating factor-dependent promyelocyte capable of biphenotypic differentiation to neutrophils or macrophages, independent of enforced meis expression. Mol Cell Biol 2000;20:3274-3285.
16. Thorsteinsdottir U, Mamo A, Kroon E, et al. Overexpression of the myeloid leukemia-associated Hoxa9 gene in bone marrow cells induces stem cell expansion. Blood 2002;99:121-129.
17. Faber J, Krivtsov AV, Stubbs MC, et al. HOXA9 is required for survival in human MLL-rearranged acute leukemias. Blood 2009;113:2375-2385.
18. Celetti A, Barba P, Cillo C, Rotoli B, Boncinelli E, Magli MC. Characteristic patterns of HOX gene expression in different types of human leukemia. Int J Cancer 1993;53:237-244.
19. Strathdee G, Holyoake TL, Sim A, et al. Inactivation of HOXA genes by hypermethylation in myeloid and lymphoid malignancy is frequent and associated with poor prognosis. Clin Cancer Res 2007;13:5048-5055.
20. Casas S, Nagy B, Elonen E, et al. Aberrant expression of HOXA9, DEK, CBL and CSF1R in acute myeloid leukemia. Leuk Lymphoma 2003;44:1935-1941.
21. Andreeff M, Ruvolo V, Gadgil S, et al. HOX expression patterns identify a common signature for favorable AML. Leukemia 2008;22:2041-2047.
22. Sakhinia E, Farahangpour M, Tholouli E, Liu Yin JA, Hoyland JA, Byers RJ. Comparison of gene-expression profiles in parallel bone marrow and peripheral blood samples in acute myeloid leukaemia by real-time polymerase chain reaction. J Clin Pathol 2006;59:1059-1065.
23. Golub TR, Slonim DK, Tamayo P, et al. Molecular classification of cancer: class discovery and class prediction by gene expression monitoring. Science 1999;286:531-537.
24. Mayotte N, Roy DC, Yao J, Kroon E, Sauvageau G. Oncogenic interaction between BCR-ABL and NUP98-HOXA9 demonstrated by the use of an in vitro purging culture system. Blood 2002;100:4177-4184.
25. Morgan R, Beguma R, Theti D, Chansa M, Pettengell R, Sohal J. HOXA9. Expression increases with age in human haemopoietic cells. Leuk Res 2005;10:1221-1222.
26. Hoshino K, Quintás-Cardama A, Radich J, Dai H, Yang H, Garcia-Manero G. Downregulation of JUNB mRNA expression in advanced phase chronic myelogenous leukemia. Leuk Res 2009;33:1361-1366.